Eloxx Pharmaceuticals Insiders
| ELOXDelisted Stock | USD 6.12 0.30 4.67% |
Eloxx Pharmaceuticals employs about 18 people. The company is managed by 6 executives with a total tenure of roughly 42 years, averaging almost 7.0 years of service per executive, having 3.0 employees per reported executive. Break down of Eloxx Pharmaceuticals' management performance can provide insight into the company performance.
| Vijay MBBS Insider Head RD |
| Barbara Ryan Insider Investor Officer |
Eloxx |
Eloxx Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.7318) % which means that it has lost $0.7318 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.1523) %, meaning that it created substantial loss on money invested by shareholders. Eloxx Pharmaceuticals' management efficiency ratios could be used to measure how well Eloxx Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Eloxx Pharmaceuticals Workforce Comparison
Eloxx Pharmaceuticals is rated # 5 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 275. Eloxx Pharmaceuticals holds roughly 18.0 in number of employees claiming about 7% of equities under Health Care industry.
Eloxx Pharmaceuticals Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Eloxx Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Eloxx Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Eloxx Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Walts Alan Edmund over a year ago Acquisition by Walts Alan Edmund of 2859 shares of Eloxx Pharmaceuticals subject to Rule 16b-3 |
Eloxx Pharmaceuticals Notable Stakeholders
An Eloxx Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Eloxx Pharmaceuticals often face trade-offs trying to please all of them. Eloxx Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Eloxx Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Vijay MBBS | Head RD | Profile | |
| Barbara Ryan | Investor Officer | Profile | |
| Ali MD | Chief Officer | Profile | |
| MBA MBA | Principal CFO | Profile | |
| Matthew Goddeeris | VP Research | Profile | |
| Sumit MBA | CEO Pres | Profile |
About Eloxx Pharmaceuticals Management Performance
The success or failure of an entity such as Eloxx Pharmaceuticals often depends on how effective the management is. Eloxx Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Eloxx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Eloxx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts. Eloxx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 28 people.
Please note, the imprecision that can be found in Eloxx Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Eloxx Pharmaceuticals. Check Eloxx Pharmaceuticals' Beneish M Score to see the likelihood of Eloxx Pharmaceuticals' management manipulating its earnings.
Eloxx Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Eloxx Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Eloxx Pharmaceuticals within its industry.Eloxx Pharmaceuticals Manpower Efficiency
Return on Eloxx Pharmaceuticals Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 2M | |
| Net Loss Per Executive | 6M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Eloxx Pink Sheet
If you are still planning to invest in Eloxx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eloxx Pharmaceuticals' history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |